Frailty in Older Adults with Heart Failure
- 1Department of Geriatrics, University Medical Center Göttingen, Robert-Koch-Str. 42, 37075 Göttingen, Germany
- 2German Center for Cardiovascular Research (DZHK), Göttingen site, Germany
Abstract
Purpose of Review: Heart failure (HF) and frailty are increasingly prevalent with population aging, frequently coexist, and share pathophysiological mechanisms. This review summarizes recent evidence on shared biological pathways and management strategies in patients with HF and frailty.
Recent Findings: Emerging data suggest that accumulation of damaged cellular components, mitochondrial dysfunction, cellular senescence, and chronic inflammation contribute to both conditions. Altered myokine-mediated signaling further highlights skeletal muscle as an important peripheral link between HF and frailty and as a potential therapeutic target. Frailty is increasingly recognized as a clinically relevant measure and potentially modifiable treatment target. Current evidence, largely derived from small or single-center studies, suggests that individualized multidomain interventions, including exercise training, nutritional optimization, and geriatric co-management, may improve patient-centered outcomes.
Summary: Management should integrate guideline-directed HF therapy with targeted treatment of geriatric syndromes, guided by multidimensional assessment and individual patient goals. Multicenter trials in frail HF populations are needed to inform evidence-based management recommendations.
Related
- Alcohol screening, counseling, and medication treatment among older adults with heart failure: A missed opportunity
- Incidence and predictors of urinary tract infections after sodium-glucose cotransporter 2 inhibitor initiation in older adults hospitalized for heart failure
- Longitudinal Trajectories of Hospitalizations in U.S. Older Adults with Heart Failure
- Exposomic Determinants in Heart Failure Among Older Adults - Mechanistic Links, Clinical Evidence, and Future Perspectives.
- Factors associated with self-care in older adults with heart failure presenting with composite and domain-specific intrinsic capacity impairment
BibTeX
@article{valentova2026frailty,
title = {{Frailty in Older Adults with Heart Failure}},
author = {Miroslava Valentová},
journal = {Current Heart Failure Reports},
year = {2026},
month = oct,
doi = {10.1007/s11897-026-00785-6},
url = {https://doi.org/10.1007/s11897-026-00785-6},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Frailty in Older Adults with Heart Failure
AU - Miroslava Valentová
PY - 2026
DA - 2026/10/31
JO - Current Heart Failure Reports
DO - 10.1007/s11897-026-00785-6
UR - https://doi.org/10.1007/s11897-026-00785-6
AB - Purpose of Review: Heart failure (HF) and frailty are increasingly prevalent with population aging, frequently coexist, and share pathophysiological mechanisms. This review summarizes recent evidence on shared biological pathways and management strategies in patients with HF and frailty. Recent Findings: Emerging data suggest that accumulation of damaged cellular components, mitochondrial dysfunction, cellular senescence, and chronic inflammation contribute to both conditions. Altered myokine-mediated signaling further highlights skeletal muscle as an important peripheral link between HF and frailty and as a potential therapeutic target. Frailty is increasingly recognized as a clinically relevant measure and potentially modifiable treatment target. Current evidence, largely derived from small or single-center studies, suggests that individualized multidomain interventions, including exercise training, nutritional optimization, and geriatric co-management, may improve patient-centered outcomes. Summary: Management should integrate guideline-directed HF therapy with targeted treatment of geriatric syndromes, guided by multidimensional assessment and individual patient goals. Multicenter trials in frail HF populations are needed to inform evidence-based management recommendations.
SN - 1546-9530
SN - 1546-9549
ER -